Bruker Enters Partnership with Cambridge Isotope Laboratories to Further Strengthen LabScape® Portfolio of NMR Solutions
BILLERICA, Massachusetts – March 29th, 2021 – Bruker is entering a partnership with Massachusetts-based Cambridge Isotope Laboratories (CIL), formalizing a long-term relationship between the two companies and further extending Bruker capabilities to deliver end-to end service solutions to its installed customer base in nuclear magnetic resonance (NMR) spectroscopy under the LabScape® brand. By adding the industry-leading specialty solvent range from CIL to its world-class portfolio of analytical instrumentation and related consumables, Bruker can now offer full after-market care, extending customer service throughout the product lifecycle.
Selecting a consistently high purity NMR solvent with minimum batch-to-batch variation for sample preparation is essential to deliver experimental repeatability and data consistency. CIL has over 40 years of experience in manufacturing deuterated solvents and NMR reference standards. The Bruker partnership with CIL will optimize the outcomes of NMR spectroscopy analysis for all customers. The service will launch in late Q2, 2021, allowing Bruker customers to purchase deuterated NMR solvents from CIL via Bruker sales channels including the LabScape® online store.
Maureen Duffy, Vice President of Sales and Marketing at CIL, commented: “We are very excited to enter into this partnership with Bruker, who has a long-standing leadership position in NMR and an extensive worldwide distribution network. Bruker’s expertise and knowledge in NMR markets and CIL’s extensive history as a manufacturer of high-quality deuterated NMR solvents is a perfect combined platform for success. We look forward to working together to better service the NMR community.”
Andreas Kamlowski, President, Service and Life Cycle Support Division at Bruker BioSpin, added: “CIL employs strict methodologies for solvent purification and adheres to class-leading standards of chemical and isotopic purity. Through this partnership, our goal is to further strengthen the value of our customer offer through leveraging each other’s competencies and experience.”
About Bruker Corporation
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
About Cambridge Isotope Laboratories
CIL is the world’s largest manufacturer and global supplier of stable isotopes and stable isotope-labeled compounds used in research, environmental, neonatal, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL is an operating business owned by Otsuka Pharmaceuticals. The CIL business consists of two facilities in the Boston, MA, area; a large isotope-enrichment production plant in Xenia, OH; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France.
For more information, please visit https://www.isotope.com/
Media Contact:
Thorsten Thiel, Ph.D.
VP of Group Marketing
Bruker BioSpin
T: +49 (721) 5161–6500
E: thorsten.thiel@bruker.com